A place for precision medicine in bladder cancer: targeting the FGFRs.

about

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis.

P2860

Q42378347-27AA047E-7572-4A8A-A783-3933C792012C Q47149560-925F2388-2D78-46E6-81D9-45B4762F9315

P2860

A place for precision medicine in bladder cancer: targeting the FGFRs.

Item

http://www.wikidata.org/entity/Q30249143

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

A place for precision medicine in bladder cancer: targeting the FGFRs.

@ast

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en-gb

type

Item

label

A place for precision medicine in bladder cancer: targeting the FGFRs.

@ast

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en-gb

prefLabel

A place for precision medicine in bladder cancer: targeting the FGFRs.

@ast

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en-gb

P1154

2-s2.0-84988640943

http://www.w3.org/2001/XMLSchema#string

P1433

Future Oncology

P1476

A place for precision medicine in bladder cancer: targeting the FGFRs.

@en

P2093

Sarah V Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

Cellular signaling by fibroblast growth factor receptors

Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor preferentially expressed in skeletal tissues

The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain

A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

Receptor specificity of the fibroblast growth factor family

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

BAR domains as sensors of membrane curvature: the amphiphysin BAR structure

P304

2243-2263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0042

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Darren C. Tomlinson

Margaret A Knowles

Erica di Martino

P5530

9631245

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039393571

http://www.w3.org/2001/XMLSchema#string

P698

27381494

http://www.w3.org/2001/XMLSchema#string

P932

5066128

http://www.w3.org/2001/XMLSchema#string

P953

102184/